Abstract
Nitric oxide (NO) is synthesized from L-arginine (ARG) by NO synthase (NOS), which can be inhibited by endogenous inhibitors such as asymmetric dimethylarginine (ADMA). A growing number of clinical studies documented a tight correlation between increased ADMA blood levels and cardiovascular morbidity and mortality. Therefore, it is highly desirable to measure ARG and its metabolites in human biological fluids. A broad range of analytical methods for the determination of ARG, ADMA, and symmetric dimethylarginine (SDMA) has been published, but there are large discrepancies in the concentration values obtained from these methods. We here describe a reference method for the determination of circulating ARG, ADMA, and SDMA, which relies on the high-performance liquid chromatography (HPLC) separation of the o-phthaldehyde derivatives of the analytes and their subsequent mass spectrometric (MS) detection. This method overcomes the problems of extensive sample preparation, unspecific detection, and external calibration. The use of isotope-labeled internal standards for ARG and ADMA leads to very precise and accurate results. With this method we found in healthy volunteers (n=47, age 20–56 years) plasma concentrations of (mean±standard deviation) 63.9±23.9 μmol/l for ARG, 0.355±0.066 μmol/l for ADMA, and 0.460±0.092 μmol/l for SDMA.
Similar content being viewed by others
References
Gary JD, Clarke S (1998) RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61:65–131
Nijveldt RJ, van Leeuwen PA, Van Guldener C, Stehouwer CD, Rauwerda JA, Teerlink T (2002) Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 17:1999–2002
Ogawa T, Kimoto M, Sasaoka K (1989) Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 264:10205–10209
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, Loscalzo J (1989) N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 65:789–795
Radomski MW, Palmer RM, Moncada S (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482–1489
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G (2001) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int Suppl 78:S14–S18
Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842–1847
Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D (2002) Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13:170–176
Park KS, Lee HW, Hong SY, Shin S, Kim S, Paik WK (1988) Determination of methylated amino acids in human serum by high-performance liquid chromatography. J Chromatogr 440:225–230
Chen BM, Xia LW, Zhao RQ (1997) Determination of N G,N G-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B 692:467–471
Pettersson A, Uggla L, Backman V (1997) Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr B 692:257–262
Meyer J, Richter N, Hecker M (1997) High-performance liquid chromatographic determination of nitric oxide synthase-related arginine derivatives in vitro and in vivo. Anal Biochem 247:11–16
Causse E, Siri N, Arnal JF, Bayle C, Malatray P, Valdiguie P, Salvayre R, Couderc F (2000) Determination of asymmetrical dimethylarginine by capillary electrophoresis-laser-induced fluorescence. J Chromatogr B 741:77–83
Vishwanathan K, Tackett RL, Stewart JT, Bartlett MG (2000) Determination of arginine and methylated arginines in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B 748:157–166
Pi J, Kumagai Y, Sun G, Shimojo N (2000) Improved method for simultaneous determination of L-arginine and its mono- and dimethylated metabolites in biological samples by high-performance liquid chromatography. J Chromatogr B 742:199–203
Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PAM (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131–137
Tsikas D, Schubert B, Gutzki FM, Sandmann J, Frölich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B 798:87–99
Zhang WZ, Kaye DM (2004) Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization. Anal Biochem 326:87–92
Albsmeier J, Schwedhelm E, Schulze F, Kastner M, Böger RH (2004) Determination of N G,N G-dimethyl-L-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry. J Chromatogr B 809:59–65
Martens-Lobenhoffer J, Krug O, Bode-Böger SM (2004) Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique. J Mass Spectrom 39:1287–1294
Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, Böger RH (2004) Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 42:1377–1383
Trapp G, Sydow K, Dulay MT, Chou T, Cooke JP, Zare RN (2004) Capillary electrophoretic and micellar electrokinetic separations of asymmetric dimethyl-L-arginine and structurally related amino acids: quantitation in human plasma. J Sep Sci 27:1483–1490
Kirchherr H, Kühn-Velten WN (2005) HPLC-tandem mass spectrometric method for rapid quantification of dimethylarginines in human plasma. Clin Chem 51:249–252
Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572–575
Das I, Khan NS, Puri BK, Hirsch SR (1996) Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett 215:209–211
Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95:2068–2074
Anderstam B, Katzarski K, Bergström J (1997) Serum levels of N G,N G-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8:1437–1442
Pettersson A, Hedner T, Milsom I (1998) Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 77:808–813
Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T (1998) Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62:2425–2430
Surdacki A, Nowicki M, Sandmann J, Tsikas D, Böger RH, Bode-Böger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Frölich JC (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33:652–658
Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T (1999) Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99:1141–1146
Kielstein JT, Böger RH, Bode–Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594–600
Fard A, Tuck CH, Donis JA, Sciacca R, Di Tullio MR, Wu HD, Bryant TA, Chen NT, Torres-Tamayo M, Ramasamy R, Berglund L, Ginsberg HN, Homma S, Cannon PJ (2000) Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20:2039–2044
Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS (2001) Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 88:1201–1203
Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P (2001) Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 38:111–116
Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG (2001) Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci 100:161–167
Yoo JH, Lee SC (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158:425–430
Zoccali C, Bode-Böger SM, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich JC, Böger RH (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113–2117
Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, Laaksonen R (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358:2127–2128
Bode-Böger SM, Muke J, Surdacki A, Brabant G, Böger RH, Frölich JC (2003) Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 8:77–81
Kielstein JT, Bode-Böger SM, Frölich JC, Ritz E, Haller H, Fliser D (2003) Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107:1891–1895
Selley ML (2003) Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease. Neurobiol Aging 24:903–907
Selley ML (2004) Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. J Affect Disord 80:249–256
Pundak S, Wilchek M (1981) Synthesis of guanidino-N-alkylarginines by the use of polymeric pseudoureas. J Org Chem 46:808–809
Martens-Lobenhoffer J, Bode-Böger SM (2003) Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation. J Chromatogr B 798:231–239
Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455–1459
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martens-Lobenhoffer, J., Bode-Böger, S.M. Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chromatography-mass spectrometry quantification. Eur J Clin Pharmacol 62 (Suppl 1), 61–68 (2006). https://doi.org/10.1007/s00228-005-0015-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0015-9